Ribociclib leverages phosphodiesterase 4 inhibition in the treatment of neutrophilic inflammation and acute respiratory distress syndrome

Po‐Jen Chen(Providence University), Tsong‐Long Hwang(Ming Chi University of Technology)
Journal of Advanced Research
March 27, 2024
Cited by 17


Related Papers